Our understanding of obesity since the discovery of leptin has revolved around the idea that BMI has a genetic basis, with approximately 4070% of the variation in BMI in the population being attributable to heritable factors [9], and that the majority of genetic variation associated with BMI is in the central nervous system (CNS) [10]
Tuesta LM, Chen Z, Duncan A, Fowler CD, Ishikawa M, Lee BR, et al
The optimal dose for metabolic support, if any, remains unclear in the scientific literature
Therapies targeting the GLP-1 receptor (GLP-1R) use the classical incretin model as a physiological framework in which GLP-1 secreted from enteroendocrine L-cells acts on the beta-cell GLP-1R
[1] Psyllium also slows gastric emptying on its own, which extends the GLP-1 response to a meal independent of fermentation